Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of Telmisartan and Amlodipine Free Dose Combination in Healthy Males
NCT02194309Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2006
- Primary completion
- Dec 2006
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of telmisartan and amlodipine in hypertension (HTN) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Clinically significant changes in vital signs (blood pressure, pulse rate, body temperature), Clinically significant changes in 12-lead electrocardiogram (ECG) and 3 more. Started Sep 2006; status: completed.
02
Drugs
telmisartanamlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02194309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194309.